AI assistant
Sending…
Aquestive Therapeutics, Inc. — Director's Dealing 2020
Aug 19, 2020
32552_dirs_2020-08-19_eb2f8cc0-4f45-4593-b217-e3e5146bb86b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2020-08-18
Reporting Person: Maxwell John T. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-18 | Common Stock | S | 3000 | $8.00 | Disposed | 150614 | Direct |
Footnotes
F1: The sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 16, 2020.
More from Aquestive Therapeutics, Inc.
Annual Report
2026
Apr 24
Regulatory Filings
2026
Mar 30
Board/Management Information
2026
Mar 20
Investor Presentation
2026
Feb 26
Regulatory Filings
2026
Feb 2
Regulatory Filings
2026
Jan 21
Regulatory Filings
2026
Jan 9
Director's Dealing
2025
Dec 5
Director's Dealing
2025
Dec 4
Regulatory Filings
2025
Nov 17